Focused Issue on Non-alcohol Fatty Liver Disease and Alcohol Liver Disease

Posted On 2019-06-25 14:56:24


This focused issue on “Non-alcohol Fatty Liver Disease and Alcohol Liver Disease” is edited by Dr. Ashwani K. Singal, Division of Gastroenterology and Hepatology, University of South Dakota, Sioux Falls, SD, USA.

Dr. Ashwani K. Singal is an Associate Professor at the University of South Dakota, Sanford School of Medicine. His clinical affiliation is as Transplant Hepatologist with the Avera McKennan University Health Center and Transplant Institute and another title at this clinical facility is Chief of Clinical Research Affairs to direct and develop clinical research program within the center specially within the division. Dr. Singal’s clinical and research interests include Alcoholic liver disease, NAFLD/NASH, Porphyria, Renal injury in cirrhosis, and Liver transplantation.

Focused issue outline:
  1. Similarities and differences between NAFLD & ALD
    Ashwani K. Singal, Division of Gastroenterology and Hepatology, University of South Dakota, Sioux Falls, SD, USA
  2. Eipdemiology of NAFLD & ALD
    Abhijit Chowdhury, Department of Hepatology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, India
  3. Pathogenesis and Pathways: NAFLD & ALD
    Vijay H. Shah, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
  4. Gut microbiome changes in NAFLD & ALD
    Puneet Puri, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
  5. Genetic & Epigenetic disease modifiers: NAFLD & ALD
    Ajay Duseja, Department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
  6. Alcohol & NAFLD
    Winston Dunn, Department of Gastroenterology and Hepatology, The University of Kansas Health System, Kansas, USA
  7. Clinical presentation of NAFLD & ALD: Spectrum and diagnosis
    Anil Arora, Institute of Liver, Gastroenterology, & Panceatico-Biliary Sciences, Sir Ganga Ram Hospital, New Delhi, India
  8. Non-invasive diagnosis: NAFLD & ALD
    Andres Duarte-Rojo, Department of Medicine, Division of Gastroenterology, UPMC, Pittsburgh, PA, USA
  9. HCC in NAFLD & ALD
    Christine Pocha, University of South Dakota, Sioux Falls, South Dakota, USA
  10. Basic science to clinical trials in NAFLD & ALD: Collaboration with industry
    Scott L. Friedman, Division of Liver Diseases, Icahn Mount Sinai School of Medicine, New York, NY, USA
  11. Emerging and newer therapies NAFLD & ALD
    Vincent WS Wong, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
  12. Cholecystectomy & NAFLD
    Ashwani K. Singal, Division of Gastroenterology and Hepatology, University of South Dakota, Sioux Falls, SD, USA